A multivariate analysis of the SITS-MOST trial indicates that routine use of alteplase in stroke patients is safe and effective

http://www.docguide.com/news/content.nsf/news/852571020057CCF6852572ED006FD3BA?OpenDocument&c=Stroke&count=10&id=48dde4a73e09a969852568880078c249

Comments are closed.